We document linezolid dependence among 5 highly linezolid-resistant (LRSE) Staphylococcus epidermidis bloodstream isolates that grew. ContextLinezolid resistance is extremely uncommon in Staphylococcus aureus.ObjectiveTo report an outbreak with linezolid and.
Linezolid remains active against )98% of Staphylococcus, with resistance identified in 0.05% of Staphylococcus aureus and 1.4% of. Linezolid-Resistant. Staphylococcus epidermidis. Portugal, 2012. To the Editor: Linezolid is a therapeutic option for skin and soft tissue infections and. Molecular epidemiology of coagulase-negative bloodstream isolates: detection of Staphylococcus epidermidis ST2, ST7 and linezolid-resistant ST23. Official Full-Text Paper (PDF): Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with.
June 8, 2010 -- First there were methicillin-resistant Staphylococcus aureus (MRSA) infections. Now there is linezolid-resistant Staphylococcus. Linezolid resistance has been reported to occur in Staphylococcus epidermidis isolates, and recently, the specific gene mutation G2576T was also reported to.
To the Editor: Linezolid is a therapeutic option for skin and soft tissue infections and pneumonia caused by multidrug-resistant gram-positive bacteria (e.g. To the Editor—Described are the first reported cases of osteomyelitis due to linezolid-resistant Staphylococcus epidermidis. Case 1 was a.